1.Current Status and Issues of Cardiovascular Surgery Institution in Community Medicine
Satoshi SUGIMOTO ; Ryota MURASE ; Hiroki UCHIYAMA ; Takamitsu TATSUKAWA ; Naohiro WAKABAYASHI ; Ayaka ARIHARA ; Masato FUSEGAWA ; Yoshinobu WATABE ; Hiroyuki MIYAMOTO ; Kei MUKAWA
Japanese Journal of Cardiovascular Surgery 2023;52(3):3-U1-3-U8
Lately, there has been a trend towards integration among cardiovascular surgery institutions. However, local institutions continue to play a crucial role in community-based medicine, given the emergent nature of cardiovascular diseases and the challenges involved in transporting patients with such conditions over long distances. We present the results of a questionnaire survey we conducted to examine the current status and issues faced by cardiovascular surgery institutions in community-based medicine.
2.Role of the Japanese Training Facilities for Young Cardiovascular Surgeons
Ryota MURASE ; Ryosuke NUMAGUCHI ; Takamitsu TATSUKAWA ; Satoshi SUGIMOTO ; Akihito OOKAWA ; Ayaka ARIHARA ; Hiroki UCHIYAMA ; Naohiro WAKABAYASHI ; Haruki NIWANO
Japanese Journal of Cardiovascular Surgery 2021;50(1):1-U1-1-U6
The Japanese board of cardiovascular surgery has changed the requirements for the certification of cardiovascular surgeons. The requirements include Off the Job Training and the training of extracorporeal circulation. The role of training facilities should be changed because of its duty. We showed a questionnaire survey about the new requirements for young cardiovascular surgeons in Hokkaido. We hope this article shows what is required for the training facilities in the new era.
3.A Successful Case of Redo-Tricuspid Valve Replacement for Prosthetic Valve Endocarditis Thirty-Two Years after Single Tricuspid Bioprosthetic Valve Replacement
Shuhei MIURA ; Yutaka IBA ; Kei MUKAWA ; Keitaro NAKANISHI ; Takakimi MIZUNO ; Ayaka ARIHARA ; Tsuyoshi SHIBATA ; Junji NAKAZAWA ; Tomohiro NAKAJIMA ; Nobuyoshi KAWAHARADA
Japanese Journal of Cardiovascular Surgery 2024;53(3):100-104
We present a successful case of redo-tricuspid valve replacement for tricuspid prosthetic valve endocarditis. A 78-year-old man who underwent tricuspid bioprosthetic valve replacement for severe tricuspid regurgitation thirty-two years earlier was referred to our institution with persistent high fever and back pain. The blood culture was positive for Streptococcus oralis, and echocardiography revealed a mobile vegetation attached to the tricuspid prosthetic valve with moderate tricuspid regurgitation. A clinical diagnosis of prosthetic valve endocarditis was established. Redo-tricuspid bioprosthetic valve replacement was performed following antibiotics therapy. The patient was discharged on postoperative day 49 after 6 weeks of additional antibiotic treatment, and had no recurrence of infection for 6 months after redo-surgery.